Kawanishi, Hitomi
Sekiguchi, Atsushi
Funaba, Misako
Fujii, Yasushi
Yoshiuchi, Kazuhiro
Kikuchi, Hiroe
Kawai, Keisuke
Maruo, Kazushi
Sugawara, Norio
Hatano, Kenji
Shoji, Tomotaka
Yamazaki, Tadahiro
Toda, Kenta
Murakami, Masafumi
Shoji, Masayasu
Ohara, Chisato
Tomita, Yoshitoshi
Fukudo, Shin
Ando, Tetsuya https://orcid.org/0000-0003-2643-6067
Funding for this research was provided by:
Intramural Research Grant (29-2) for Neurological and Psychiatric Disorders of NCNP (29-2)
Giant-in-Aid for Scientific Research from the MHLW (H29-Nanbyou-Ippan-059)
Nakatomi Foundation (NA)
Article History
Received: 28 February 2019
Accepted: 16 May 2019
First Online: 6 June 2019
Ethics approval and consent to participate
: Ethics approval has been granted by the Institutional Review Board of the National Center of Neurology and Psychiatry in Tokyo, Japan (accepted on November 29, 2017; A2017–067). All participants will be informed about the details of the trial, including the purpose, arrangement, probable risks, benefits, and subjects’ rights and obligations. Signed informed consent will be obtained from all participants before enrollment.
: The consent for publication was included in the consent to participate form.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.